Hologic, Inc. $1,500,000,000 2.00% Convertible Senior Notes due 2037Underwriting Agreement • December 10th, 2007 • Hologic Inc • X-ray apparatus & tubes & related irradiation apparatus • New York
Hologic, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters”) $1,500,000,000 in aggregate principal amount of its convertible senior notes due 2037 (the “Firm Securities”) convertible into shares of the Company’s common stock, par value $0.01 per share (the “Stock”), and, at the election of the Underwriters, up to an aggregate of $225,000,000 in additional principal amount of the Company’s convertible senior notes due 2037 (the “Optional Securities”) (the Firm Securities and the Optional Securities that the Underwriters elect to purchase pursuant to Section 2 hereof being collectively called the “Securities”).
INDENTURE BETWEEN HOLOGIC, INC., AND WILMINGTON TRUST COMPANY, AS TRUSTEEHologic Inc • December 10th, 2007 • X-ray apparatus & tubes & related irradiation apparatus • New York
INDENTURE, dated as of December 10, 2007, between Hologic, Inc., a Delaware corporation (the “Company”), having its principal office at 35 Crosby Drive, Bedford, Massachusetts 01730 and Wilmington Trust Company, a Delaware banking corporation, as trustee (herein called the “Trustee”).
